ArticleJournal of hematology & oncology2021

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.

Ming Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.